Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Investigation of the expression of pro-angiogenic markers in cutaneous tumours in vivo and in vitro

Dissertation (MSc (Human Physiology))--University of Pretoria, 2023.

Saved in:
Bibliographic Details
Other Authors: Mabeta, Peace
Format: Thesis
Language:English
Published: University of Pretoria 2023
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613676354142208
access_status_str Open Access
author2 Mabeta, Peace
author_browse Mabeta, Peace
author_facet Mabeta, Peace
collection Thesis
dc_rights_str_mv © 2023 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria.
description Dissertation (MSc (Human Physiology))--University of Pretoria, 2023.
format Thesis
id oai:repository.up.ac.za:2263/90582
institution University of Pretoria (South Africa)
language English
last_indexed 2026-06-10T12:39:56.028Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher University of Pretoria
publisherStr University of Pretoria
record_format dspace
source_str UPSpace — University of Pretoria Institutional Repository
spelling oai:repository.up.ac.za:2263/90582 Investigation of the expression of pro-angiogenic markers in cutaneous tumours in vivo and in vitro Mabeta, Peace u20799978@tuks.co.za Bida, Meshack Nonxuba, Masibulele Cutaneous tumour Melanoma Angiogenesis Haemangioma Growth factors UCTD Dissertation (MSc (Human Physiology))--University of Pretoria, 2023. Cutaneous tumours are common types of cancers that develop from the skin and account for 40% of the cases worldwide. In particular, melanomas and cutaneous haemangiomas are commonly occurring skin tumours that are characterised by aggressive growth. Angiogenesis, the development of cutaneous tumours such as haemangioma and melanoma, has been associated with angiogenesis the formation of new blood vessels from existing vasculature - promoting tumour proliferation, survival, and metastasis in the case of melanoma. As a result, there is a need to identify angiogenic markers as a tool that could systematically disrupt the vessel formation process. This study aimed to investigate markers of angiogenesis in cutaneous tumour cells and biopsies. Endothelial cells cultured in different medium conditions (normal, melanoma-conditioned, and serum-free) were analysed for growth and cell morphology. Vascular endothelial growth factor-A (VEGF-A), basic fibroblast growth factor and platelet-derived growth factor-BB (PDGF-BB) were quantified in an ELISA kit to determine their expression level as angiogenic biomolecular markers, employing melanoma B16-F10 cell lines. Formalin-fixed haemangioma biopsy tissues were investigated for the presence of EC using IHC and a light microscope. The expression of Bcl-2 and VEGF-R were also analysed following immunoreactivity against appropriate antibodies. In this study, a time-dependent cell growth assay was employed, using crystal violet as the investigative tool. The results of this study demonstrated that the cells grown in a melanoma-conditioned environment induced a proliferative effect while those incubated with serum-free medium exhibited cell growth inhibition. When cells were treated with a dose-dependent Nocodazole, cell growth inhibition was also initiated. The cells showed a healthy spindle-like shape with well-defined nucleoli in both conditions. No morphological difference existed between the cell populations cultured in a different medium. High expression levels of VEGF-A and bFGF in melanoma B16-F10 cells were identified and significantly (p < 0.05) associated with the progression of the disease. Although no scientific significance was found for PDGF in the cutaneous tumour cells, their expression was depicted. Dilated vessels with red blood cells were observed in tumour tissues of haemangioma. While the expression of Bcl-2 in cutaneous tumour tissues was barely expressed, the antibodies against VEGF-R strongly depicted the molecular expression. In conclusion, the collectively identified molecular markers in vivo and in vitro serve as potential prognostic markers that could enable clinicians to diagnose the disease early and lower its burden through revolutionised anti-angiogenic therapy. National Research Foundation Angiogenesis Lab Funds Physiology MSc (Human Physiology) Unrestricted 2023-05-08T09:14:08Z 2023-05-08T09:14:08Z 2023-09 2023 Dissertation * S2023 http://hdl.handle.net/2263/90582 10.25403/UPresearchdata.22769978 en © 2023 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. application/pdf University of Pretoria
spellingShingle Cutaneous tumour
Melanoma
Angiogenesis
Haemangioma
Growth factors
UCTD
Investigation of the expression of pro-angiogenic markers in cutaneous tumours in vivo and in vitro
title Investigation of the expression of pro-angiogenic markers in cutaneous tumours in vivo and in vitro
title_full Investigation of the expression of pro-angiogenic markers in cutaneous tumours in vivo and in vitro
title_fullStr Investigation of the expression of pro-angiogenic markers in cutaneous tumours in vivo and in vitro
title_full_unstemmed Investigation of the expression of pro-angiogenic markers in cutaneous tumours in vivo and in vitro
title_short Investigation of the expression of pro-angiogenic markers in cutaneous tumours in vivo and in vitro
title_sort investigation of the expression of pro angiogenic markers in cutaneous tumours in vivo and in vitro
topic Cutaneous tumour
Melanoma
Angiogenesis
Haemangioma
Growth factors
UCTD
url http://hdl.handle.net/2263/90582